GNH USA

Europe — EMA

Indapamida Krka

GNH USA supplies Indapamida Krka (Indapamide), a thiazide-like diuretic for the treatment of hypertension and fluid retention.

Indapamide

Request sourcing

1
Pack/s

What is Indapamide?

Indapamide, the active ingredient in Indapamida Krka, is a thiazide‑like diuretic presented as a tablet (strength not specified) for oral use. It treats hypertension and helps reduce edema in patients with heart or renal disease.

GNH USA supplies Indapamida Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Indapamide used for?

Indapamide is a thiazide‑like diuretic used to manage conditions related to fluid overload and elevated blood pressure.

- Hypertension: lowers systemic blood pressure and reduces cardiovascular risk. - Edema associated with heart failure: promotes fluid excretion to relieve swelling. - Edema associated with renal disease: enhances diuresis to decrease peripheral edema.

What are the side effects of Indapamide?

Indapamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Increased urination: more frequent need to void. - Electrolyte imbalance (low potassium): may cause muscle weakness. - Dizziness or light‑headedness: especially on standing. - Headache: mild to moderate intensity. - Fatigue: general feeling of tiredness. - Elevated blood glucose: may affect diabetic control.

Serious or Rare Side Effects: - Severe dehydration: risk of hypotension and renal impairment. - Significant electrolyte disturbances (hypokalemia, hyponatremia): can lead to cardiac arrhythmias. - Gout attacks: increased uric acid levels. - Allergic reactions: rash, itching, or angioedema. - Blood dyscrasias: rare cases of leukopenia or thrombocytopenia. - Acute renal failure: especially in patients with pre‑existing kidney disease.

What precautions apply to Indapamide?

When prescribing Indapamide, clinicians should consider several safety measures.

- Monitor electrolytes: regular blood tests to detect potassium or sodium changes. - Assess renal function: adjust therapy if creatinine clearance is reduced. - Evaluate blood pressure: avoid excessive hypotension, especially in the elderly. - Use caution in diabetes: monitor glucose as the drug may raise blood sugar. - Discontinue if hypersensitivity occurs: stop immediately upon signs of allergic reaction. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

What does Indapamide interact with?

Indapamide interacts with several drug classes; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Lithium: increased lithium toxicity. - NSAIDs: reduced diuretic efficacy and possible renal impairment. - ACE inhibitors or ARBs: heightened risk of renal dysfunction and hyperkalemia. - Other thiazide diuretics: additive electrolyte loss. - Digoxin: enhanced digoxin toxicity due to electrolyte shifts.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive blood‑pressure lowering effect. - Corticosteroids: increased potassium loss. - Antidiabetic agents: possible alteration of glucose control. - Calcium supplements or vitamin D: risk of hypercalcemia. - Alcohol: may exacerbate dizziness and hypotension.

Frequently asked questions

What conditions is Indapamida Krka used for?+
Indapamida Krka contains indapamide, a thiazide‑like diuretic indicated for the management of hypertension and for reducing edema associated with heart failure or renal disease. It helps lower blood pressure and promotes the removal of excess fluid from the body.
How does indapamide work in the body?+
Indapamide blocks the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney, reducing reabsorption of sodium and water. This leads to increased urine output, decreased plasma volume, and lowered peripheral vascular resistance, which together lower blood pressure and reduce fluid accumulation.
What is the usual dose of Indapamida Krka?+
The appropriate dose of Indapamida Krka is determined by the prescribing healthcare professional based on the patient’s condition, age, kidney function, and response to therapy. Patients should follow the exact regimen provided by their prescriber and not adjust the dose on their own.
Is Indapamida Krka safe during pregnancy or breastfeeding?+
Safety of indapamide in pregnancy or lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.
How do I order Indapamida Krka from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Indapamida Krka compare with other diuretics?+
Indapamide belongs to the thiazide‑like diuretic class and offers a longer duration of action with a lower risk of certain metabolic side effects compared with traditional thiazides. It is often preferred when a sustained antihypertensive effect and effective edema control are needed, but the choice depends on individual patient factors.
What are the storage requirements for Indapamida Krka?+
Store Indapamida Krka at room temperature, below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.
How is Indapamida Krka administered?+
Indapamida Krka is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional.
What are the most serious risks associated with Indapamida Krka?+
Serious risks include severe dehydration, significant electrolyte disturbances such as hypokalemia or hyponatremia, acute kidney injury, and rare allergic reactions. Patients should be monitored regularly for signs of these conditions, especially during the initial phases of therapy.
Who should not use Indapamida Krka?+
Indapamida Krka should be avoided in individuals with known hypersensitivity to indapamide or other sulfonamide drugs, in patients with severe renal impairment, and in those who are unable to maintain adequate fluid and electrolyte balance without close medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Indapamide
Route
Oral Use
Manufacturer
Krka Farmacêutica, Unipessoal Lda.
Origin
EU

Related products